Boston Scientific said about 13% of devices from its Accolade family of pacemakers built before September 2018 face an increased potential to initiate “safety mode,” a non-programmable backup ...
Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback